The Rarest Cannabinoid in Hemp
Most people in the hemp and wellness space are familiar with CBD. A growing number know about CBN. But very few have heard of CBG — and that's a missed opportunity.
CBG, or cannabigerol, is often called the "mother cannabinoid" because it is the biochemical precursor from which CBD, THC, and CBC are all derived. Without CBG, none of the other major cannabinoids would exist. Yet because the hemp plant converts most of its CBG into other compounds as it matures, CBG is found in very small concentrations in finished plant material — typically less than 1% by weight.
This scarcity has made CBG one of the most expensive and difficult cannabinoids to isolate, which is why it remains relatively unknown outside of research circles.
How CBG Is Formed
During the early stages of hemp plant growth, the plant produces CBGA (cannabigerolic acid) — the acidic precursor to CBG. As the plant matures, enzymes convert CBGA into THCA, CBDA, and CBCA, which then decarboxylate into THC, CBD, and CBC when exposed to heat or light.
By the time hemp is harvested, nearly all of the CBGA has been converted. This is why CBG-rich extracts require either early-harvest hemp or specially bred high-CBG cultivars — both of which command a significant premium.
At Divine Earth Theory, our Full Cryosonic Extract™ process preserves the full cannabinoid profile of the plant at peak maturity, capturing trace amounts of CBG alongside CBD and other minor cannabinoids. This is one reason full-spectrum extracts outperform isolates — you get the complete picture.
What the Research Shows
CBG interacts with the endocannabinoid system differently than CBD. While CBD works primarily by modulating CB1 and CB2 receptor activity indirectly, CBG binds directly to both receptor types — giving it a distinct and potentially complementary mechanism of action.
Early preclinical research has explored CBG's potential in several areas:
Neuroprotection. A 2015 study published in Neurotherapeutics found that CBG showed neuroprotective properties in a mouse model of Huntington's disease, reducing neuroinflammation and oxidative stress markers.
Antibacterial activity. A 2020 study in ACS Infectious Diseases found CBG effective against MRSA (methicillin-resistant Staphylococcus aureus), one of the most antibiotic-resistant bacterial strains known.
Appetite stimulation. A 2016 study in Psychopharmacology found that CBG significantly increased food intake in rats without producing the psychoactive effects associated with THC — suggesting potential applications for appetite-related conditions.
Intraocular pressure. Early research has explored CBG's potential role in reducing intraocular pressure, which is relevant to glaucoma management.
It is important to note that most CBG research is preclinical — conducted in cell cultures or animal models — and has not yet been replicated in large-scale human clinical trials. These findings are promising but not conclusive.
CBG vs. CBD: What's the Difference?
| Property | CBD | CBG | |---|---|---| | Abundance in hemp | High (up to 25%) | Very low (<1%) | | Receptor binding | Indirect (CB1/CB2 modulation) | Direct (CB1/CB2 agonist) | | Psychoactive | No | No | | Research maturity | Extensive | Early-stage | | Cost to produce | Moderate | High |
Both cannabinoids are non-psychoactive and well-tolerated in the available research. The key difference is mechanism: CBD tends to modulate and regulate, while CBG may have a more direct activating effect on certain receptors.
Why Full-Spectrum Matters for CBG
You won't find meaningful CBG concentrations in CBD isolate products. By definition, isolate contains only one cannabinoid — everything else has been stripped away. Broad-spectrum products may retain some CBG, but the processing required to remove THC often degrades minor cannabinoids in the process.
Full-spectrum hemp extract, produced from high-quality source material using a gentle extraction method, is the most reliable way to access the complete cannabinoid profile — including trace CBG, CBC, CBN, and the terpenes and flavonoids that contribute to the entourage effect.
This is the foundation of everything we formulate at Divine Earth Theory.
The Bottom Line
CBG is rare, expensive to produce, and still in the early stages of clinical research. But its unique mechanism of action and the preliminary findings across multiple research domains make it one of the most interesting minor cannabinoids in the hemp plant.
If you're evaluating hemp extract products, look for full-spectrum formulations from brands that can demonstrate their sourcing and extraction quality. The presence of CBG — even in trace amounts — is a reliable indicator that the extract has been produced with care and minimal processing.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Explore our full-spectrum formulations →